HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation

J Mikulska, G Juszczyk, M Gawrońska-Grzywacz… - Brain sciences, 2021 - mdpi.com
The hypothalamic-pituitary-adrenal (HPA) axis is involved in the pathophysiology of many
neuropsychiatric disorders. Increased HPA axis activity can be observed during chronic …

Depression and cardiovascular disease in elderly: Current understanding

Y Zhang, Y Chen, L Ma - Journal of Clinical Neuroscience, 2018 - Elsevier
Geriatric depression is a major public health problem and has an especially large effect on
health when comorbid with a chronic medical condition. Hypertension, coronary heart …

Genetics factors in major depression disease

M Shadrina, EA Bondarenko, PA Slominsky - Frontiers in psychiatry, 2018 - frontiersin.org
Depressive disorders (DDs) are one of the most widespread forms of psychiatric pathology.
According to the World Health Organization, about 350 million people in the world are …

[HTML][HTML] Adult neurogenesis in humans: a review of basic concepts, history, current research, and clinical implications

A Kumar, V Pareek, MA Faiq, SK Ghosh… - Innovations in clinical …, 2019 - ncbi.nlm.nih.gov
Neurogenesis in adult humans remains a controversial area of research among
neuroscientists. Methodological challenges have hampered investigators from conducting …

The FKBP51 glucocorticoid receptor co-chaperone: regulation, function, and implications in health and disease

GR Fries, NC Gassen, T Rein - International journal of molecular sciences, 2017 - mdpi.com
Among the chaperones and co-chaperones regulating the glucocorticoid receptor (GR),
FK506 binding protein (FKBP) 51 is the most intensely investigated across different …

[HTML][HTML] Linalool as a therapeutic and medicinal tool in depression treatment: A review

ÉRQ Dos Santos, JGS Maia… - Current …, 2022 - ncbi.nlm.nih.gov
Depression is a prevalent disease worldwide, limiting psychosocial functioning and
thequality of life. Linalool is the main constituent of some essential oils from aromatic plants …

Molecular neurobiology and promising new treatment in depression

SW Jeon, YK Kim - International journal of molecular sciences, 2016 - mdpi.com
The limited effects of currently available antidepressants are becoming an urgent issue in
depression research. It takes a long time to determine treatment effects, and the overall …

Plant-derived natural medicines for the management of depression: an overview of mechanisms of action

MS Farahani, R Bahramsoltani, MH Farzaei… - Reviews in the …, 2015 - degruyter.com
Depression is a serious widespread psychiatric disorder that affects approximately 17% of
people all over the world. Exploring the neurological mechanisms of the antidepressant …

Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice

AE Freitas, J Egea, I Buendia, V Gómez-Rangel… - Molecular …, 2016 - Springer
Agmatine, an endogenous neuromodulator, is a potential candidate to constitute an
adjuvant/monotherapy for the management of depression. A recent study by our group …

Stress-related immune markers in depression: implications for treatment

MM Hughes, TJ Connor, A Harkin - International Journal of …, 2016 - academic.oup.com
Major depression is a serious psychiatric disorder; however, the precise biological basis of
depression still remains elusive. A large body of evidence implicates a dysregulated …